awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33785927-6DE08121-BDE6-422B-B894-04ADF2135423
Q33785927-6DE08121-BDE6-422B-B894-04ADF2135423
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33785927-6DE08121-BDE6-422B-B894-04ADF2135423
A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602).
P2860
Q33785927-6DE08121-BDE6-422B-B894-04ADF2135423
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33785927-6DE08121-BDE6-422B-B894-04ADF2135423
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3674139a05966153f390d08a653aac382d6e4431
P2860
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.